According to 2024 American Society of Anesthesiologists (ASA) multi-society guidance, most patients can continue GLP-1 receptor agonists perioperatively, but individualized risk assessment is recommended
GLP-1 receptors exist on osteoblasts, and some data suggest that GLP-1 receptor activation may have bone-protective effects independent of weight loss
By addressing these challenges head-on, we can ensure that innovation serves its intended purpose: improving patient outcomes without compromising safety
Starting on a lower dose helps your body build tolerance, especially to stomach-related side effects such as nausea, vomiting and diarrhoea
Additionally, these medications are designed to be taken long-term (a year or longer)
Los agonistas del receptor GLP-1 imitan una hormona natural que regula la glucosa en sangre y el apetito